Unlike patients in other fields of medicine, those who are designated mentally ill–or even declared to be "at risk" for mental illness in the future–are at once stigmatized and suffer losss of their autonomy.
Dr. Charles Schulz is scheduled to present "How to help parents of a first psychotic episode patient," at Annual APA Meeting –it is closed to public. What is it that psychiatrists and the APA do not want parents or the public to know?
"500 people would need to be treated with Crestor for a year to avoid one usually survivable heart attack. Stroke numbers were similar…At $3.50 a pill, the cost of prescribing Crestor to 500 people for a year would be $638,000 to prevent one heart attack."
"For her last month of life, Kifuji overall prescribed 835 pills to Rebecca….If what Dr. Kifuji did in this case is the acceptable standard of care for children in Massachusetts, then there is something very wrong in this state."
"Among all the problematic suggestions for DSM5, the proposal for a "Psychosis Risk Syndrome" stands out as the most ill–conceived and potentially harmful." Allen Frances, MD
In response to yesterday’s AHRP Infomail (March 5) in which we informed readers that Dr. Gilbert Ross, the Medical Director of the American Council on Science and Helath (ACSH), the author of a WT OpEd (March 4, 2010), is a convicted felon, whose medical license was revoked after serving two years in prison for healthcare fraud:
Pit-bull attack against Sen. Grassely, Sen. Baucus and FDA safety officer, David Graham MD by a fellon whose medical license was revoked for Medicaid fraud: "I violated every ethical trust placed in me as a doctor."
"Judith Warner’s book illustrates the perils of preferring stories to science."
One has to wonder why discovery of defective cars are front page news while defective FDA-approved prescription drugs are accepted as part of life’s risk.
GSK Executives: "frankly, the last thing we want to do is get into a public debate about whose analysis is right."
Even worse, FDA officials, in collusion and collaboration with GSK, approved an unethical and exploitative clinical trial—TIDE, which is on-going.
Given multiple prior investigations of Dr. Wakefied’s 1998 paper, why did it take the Lancet editors 12 years to discover a lack of proper IRB approval?
